Altered Fatty Acid Oxidation in Lymphocyte Populations of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome
Overview
Chemistry
Molecular Biology
Affiliations
Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) is a disabling multisystem illness in which individuals are plagued with fatigue, inflammatory symptoms, cognitive dysfunction, and the hallmark symptom, post-exertional malaise. While the cause of this disease remains unknown, there is evidence of a potential infectious component that, along with patient symptoms and common onsets of the disease, implicates immune system dysfunction. To further our understanding of the state of ME/CFS lymphocytes, we characterized the role of fatty acids in isolated Natural Killer cells, CD4+ T cells, and CD8+ T cells in circulation and after overnight stimulation, through implicit perturbations to fatty acid oxidation. We examined samples obtained from at least 8 and as many as 20 subjects for immune cell fatty acid characterization in a variety of experiments and found that all three isolated cell types increased their utilization of lipids and levels of pertinent proteins involved in this metabolic pathway in ME/CFS samples, particularly during higher energy demands and activation. In T cells, we characterized the cell populations contributing to these metabolic shifts, which included CD4+ memory cells, CD4+ effector cells, CD8+ naïve cells, and CD8+ memory cells. We also discovered that patients with ME/CFS and healthy control samples had significant correlations between measurements of CD4+ T cell fatty acid metabolism and demographic data. These findings provide support for metabolic dysfunction in ME/CFS immune cells. We further hypothesize about the consequences that these altered fuel dependencies may have on T and NK cell effector function, which may shed light on the illness's mechanism of action.
Clarke K, Kingdon C, Hughes M, Lacerda E, Lewis R, Kruchek E J Transl Med. 2025; 23(1):149.
PMID: 39905423 PMC: 11792299. DOI: 10.1186/s12967-025-06146-6.
van Campen C, Rowe P, Visser F J Clin Med. 2025; 13(24.
PMID: 39768649 PMC: 11677391. DOI: 10.3390/jcm13247726.
Iu D, Maya J, Vu L, Fogarty E, McNairn A, Ahmed F Proc Natl Acad Sci U S A. 2024; 121(50):e2415119121.
PMID: 39621903 PMC: 11648872. DOI: 10.1073/pnas.2415119121.
Haunhorst S, Dudziak D, Scheibenbogen C, Seifert M, Sotzny F, Finke C Infection. 2024; 53(1):1-13.
PMID: 39240417 PMC: 11825644. DOI: 10.1007/s15010-024-02386-8.
Bulbule S, Gottschalk C, Drosen M, Peterson D, Arnold L, Roy A J Cent Nerv Syst Dis. 2024; 16:11795735241271675.
PMID: 39161795 PMC: 11331476. DOI: 10.1177/11795735241271675.